Skintra Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.12 M
as on 17-12-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 132.75%
(FY 2022)
- Profit 6.50%
(FY 2022)
- Ebitda 8.37%
(FY 2022)
- Net Worth 40.95%
(FY 2022)
- Total Assets 2.14%
(FY 2022)
About Skintra Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Rohit Batra, Abhishek Gupta, Anil Ganjoo, and Three other members serve as directors at the Company.
- CIN/LLPIN
U33309DL2017PTC321254
- Company No.
321254
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Skintra Lifesciences?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Batra  | Director | 26-Jul-2017 | Current |
| Abhishek Gupta | Director | 26-Jul-2017 | Current |
| Anil Ganjoo | Director | 26-Jul-2017 | Current |
| Amit Luthra | Director | 26-Jul-2017 | Current |
| Rajinder Gupta | Director | 26-Jul-2017 | Current |
| Sumit Gupta | Director | 26-Jul-2017 | Current |
Financial Performance of Skintra Lifesciences.
Skintra Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 132.75% increase. The company also saw a slight improvement in profitability, with a 6.5% increase in profit. The company's net worth Soared by an impressive increase of 40.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skintra Lifesciences?
In 2022, Skintra Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dermaworld Skin And Hair Clinics Private LimitedActive 14 years 8 monthsRohit Batra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Skintra Lifesciences?
Unlock and access historical data on people associated with Skintra Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skintra Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skintra Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
